CD8A and neoplasm: A meta-analysis of ten studies with 1815 OV patients demonstated the prognostic value of intraepithelial CD8+ tumor-infiltrating lymphocyte (TIL), regardless of tumor grade, stage, or histological subtype although it should be noted that heterogeneity between studies was significant (Hwang et al. 2012).